Detalhe da pesquisa
1.
Prostate cancer cells home to bone using a novel in vivo model: modulation by the integrin antagonist GLPG0187.
Int J Cancer
; 136(7): 1731-40, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25156971
2.
Low-dose methotrexate in myeloproliferative neoplasm models.
Haematologica
; 102(9): e336-e339, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28550185
3.
Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche.
J Immunother Cancer
; 9(3)2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741729
4.
Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models.
J Bone Miner Res
; 34(5): 783-796, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30320927
5.
ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo.
PLoS One
; 13(6): e0199517, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29924867
6.
Melphalan modifies the bone microenvironment by enhancing osteoclast formation.
Oncotarget
; 8(40): 68047-68058, 2017 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28978095
7.
Real-time intravital imaging establishes tumor-associated macrophages as the extraskeletal target of bisphosphonate action in cancer.
Cancer Discov
; 5(1): 35-42, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25312016
8.
Thyrostimulin Regulates Osteoblastic Bone Formation During Early Skeletal Development.
Endocrinology
; 156(9): 3098-113, 2015 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26018249
9.
Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche.
Nat Commun
; 6: 8983, 2015 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26632274
10.
iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer.
PLoS One
; 7(2): e30885, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22355332